# Oxford Nanopore Technologies plc (ONTTF)

> Healthcare · GB · Reports in GBP

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ONTTF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | £ 223.86M | £ -145.18M | £ -70.50M | £ 41.49M | £ 463.22M |
| 2024 | £ 190.38M | £ -151.92M | £ -164.74M | £ 45.96M | £ 586.34M |
| 2023 | £ 182.54M | £ -166.23M | £ -162.13M | £ 41.66M | £ 643.85M |
| 2022 | £ 222.54M | £ -101.99M | £ -99.05M | £ 34.10M | £ 693.56M |
| 2021 | £ 163.61M | £ -205.17M | £ -103.70M | £ 24.80M | £ 703.98M |
| 2020 | £ 146.12M | £ -78.60M | £ -116.05M | £ 23.63M | £ 185.93M |
| 2019 | £ 67.37M | £ -93.45M | £ -102.19M | £ 19.08M | £ 109.53M |
| 2018 | £ 42.63M | £ -69.64M | £ -96.11M | £ 9.50M | £ 142.89M |
| 2017 | £ 18.44M | £ -75.60M | £ -115.09M | £ 9.50M | £ 93.58M |
| 2016 | £ 6.22M | £ -81.19M | £ -74.51M | £ 0 | £ 144.24M |
| 2015 | £ 1.04M | £ -53.85M | £ -47.69M | £ 0 | £ 99.71M |
| 2014 | £ 0 | £ -51.96M | £ -49.91M | £ 0 | £ 65.61M |
| 2013 | £ 0 | £ -34.27M | £ -33.98M | £ 0 | £ 65.57M |
| 2012 | £ 215.7K | £ -27.65M | £ -31.95M | £ 0 | £ -56.19M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.09 |
| Liabilities / Eq | 0.34 |
| Current Ratio | 3.56 |

## Other views

- [Metrics](https://sponda.capital/en/ONTTF.md)
- [Charts](https://sponda.capital/en/ONTTF/charts.md)
- [Compare](https://sponda.capital/en/ONTTF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.